RxDoctor Payments Data

James Humpal, PA

Physician Assistant · West Allis, WINPI 1881170991

Payments from drug & device makers

$2,374in general payments, 2019–2025

Across 40 payments — averaging $59.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Boston Scientific$253
  • Actelion Pharmaceuticals US, Inc.$246
  • Boehringer Ingelheim$228
  • Medtronic$204
  • AstraZeneca$144
  • plus $70 from 2 others

What the payments were for

  • Food & beverage$2,27496%
  • Education$1004%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,374 in reported general payments places this provider in the 90th percentile of 2,804 physician assistant providers in Wisconsin.

See all physician assistant providers in Wisconsin

Medicare billing

Part B allowed, 2024
$11,466
Medicare patients
103
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$31,839
EntrestoSacubitril/Valsartan14$24,328
BrilintaTicagrelor30$23,728
XareltoRivaroxaban15$23,164
Metoprolol Succinate120$1,486
Valsartan23$1,277
Diltiazem 24hr Er (Cd)Diltiazem Hcl15$1,127
Atorvastatin Calcium105$953
Potassium Chloride59$678
Carvedilol67$563
Spironolactone54$528
Torsemide22$514
Losartan Potassium55$417
Rosuvastatin Calcium40$399
ClopidogrelClopidogrel Bisulfate40$383

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$22$24,32814 claims
AstraZenecaBrilinta$144$23,72830 claims
Johnson & JohnsonXarelto$1,229$23,16415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,804 physician assistant providers in Wisconsin.

Other physician assistant in West Allis

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →